These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32305243)

  • 1. Prostatic Artery Embolization for Benign Prostatic Hyperplasia: Bleomycin-Eluting versus Bland Microspheres in a Canine Model.
    Zhang JL; Yuan B; Wang MQ; Fu JX; Duan F; Wang T; Shen L; Wang Y; Liu JH; Shen YG; Wang XQ; Zhang HT; Li HW; Yan JY; Song ZG
    J Vasc Interv Radiol; 2020 May; 31(5):820-830. PubMed ID: 32305243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Clinical Outcomes of Prostatic Artery Embolization with 50-μm Plus 100-μm Polyvinyl Alcohol (PVA) Particles versus 100-μm PVA Particles Alone: A Prospective Randomized Trial.
    Wang MQ; Zhang JL; Xin HN; Yuan K; Yan J; Wang Y; Zhang GD; Fu JX
    J Vasc Interv Radiol; 2018 Dec; 29(12):1694-1702. PubMed ID: 30297313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia.
    Moschouris H; Stamatiou K; Malagari K; Marmaridou K; Kladis-Kalentzis K; Kiltenis M; Papadogeorgopoulos N; Tsavari A; Manoloudaki K
    Diagn Interv Radiol; 2019 Mar; 25(2):134-143. PubMed ID: 30860077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic artery occlusion versus prostatic artery embolisation for the management of benign prostatic hyperplasia: early results in a canine model.
    Lucas-Cava V; Sánchez-Margallo FM; Dávila-Gómez L; Lima-Rodríguez JR; Sun F
    Br J Radiol; 2022 Aug; 95(1136):20220243. PubMed ID: 35762334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign prostatic hyperplasia after prostatic arterial embolization in a canine model: A 3T multiparametric MRI and whole-mount step-section pathology correlated longitudinal study.
    Li B; Xu A; Wang N; Min X; Feng Z; Deng M; Li L; Cai J; Kang Z; Jiang K; Kuang D; Wang L
    J Magn Reson Imaging; 2017 Oct; 46(4):1220-1229. PubMed ID: 28182304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic Artery Embolization for Benign Prostatic Hyperplasia: Prospective Randomized Trial of 100-300 μm versus 300-500 μm versus 100- to 300-μm + 300- to 500-μm Embospheres.
    Torres D; Costa NV; Pisco J; Pinheiro LC; Oliveira AG; Bilhim T
    J Vasc Interv Radiol; 2019 May; 30(5):638-644. PubMed ID: 31029381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study.
    Bilhim T; Pisco J; Campos Pinheiro L; Rio Tinto H; Fernandes L; Pereira JA; Duarte M; Oliveira AG
    J Vasc Interv Radiol; 2013 Nov; 24(11):1595-602.e1. PubMed ID: 23916874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia.
    Insausti I; Sáez de Ocáriz A; Galbete A; Capdevila F; Solchaga S; Giral P; Bilhim T; Isaacson A; Urtasun F; Napal S
    J Vasc Interv Radiol; 2020 Jun; 31(6):882-890. PubMed ID: 32249193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-vesical Prostatic Protrusion (IPP) Can Be Reduced by Prostatic Artery Embolization.
    Lin YT; Amouyal G; Thiounn N; Pellerin O; Pereira H; Del Giudice C; Déan C; Sapoval M
    Cardiovasc Intervent Radiol; 2016 May; 39(5):690-695. PubMed ID: 26542027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Clinical Trial of Balloon Occlusion versus Conventional Microcatheter Prostatic Artery Embolization for Benign Prostatic Hyperplasia.
    Bilhim T; Costa NV; Torres D; Pisco J; Carmo S; Oliveira AG
    J Vasc Interv Radiol; 2019 Nov; 30(11):1798-1806. PubMed ID: 31587950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-Control Comparison of Conventional End-Hole versus Balloon-Occlusion Microcatheter Prostatic Artery Embolization for Treatment of Symptomatic Benign Prostatic Hyperplasia.
    Ayyagari R; Powell T; Staib L; Chapiro J; Schoenberger S; Devito R; Pollak J
    J Vasc Interv Radiol; 2019 Sep; 30(9):1459-1470. PubMed ID: 31375451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia.
    Costa NV; Torres D; Pisco J; Pinheiro LC; Martins FE; Oliveira AG; Bilhim T
    J Vasc Interv Radiol; 2020 Aug; 31(8):1272-1280. PubMed ID: 32741552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative study of prostatic artery embolization in the treatment of benign prostatic hyperplasia with different prostatic volume].
    Zhang JL; Wang MQ; Duan F; Yuan B
    Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(31):2435-2439. PubMed ID: 31434423
    [No Abstract]   [Full Text] [Related]  

  • 14. The STREAM Trial (Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia) 24-Month Clinical and Radiological Outcomes.
    Tapping CR; Little MW; Macdonald A; Mackinnon T; Kearns D; Macpherson R; Crew J; Boardman P
    Cardiovasc Intervent Radiol; 2021 Mar; 44(3):436-442. PubMed ID: 33210152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Nonspherical Polyvinyl Alcohol Particles and Microspheres for Prostatic Arterial Embolization in Patients with Benign Prostatic Hyperplasia.
    Hwang JH; Park SW; Chang IS; Jung SI; Jeon HJ; Lho YS; Kim HG; Paick SH; Park HK
    Biomed Res Int; 2017; 2017():8732351. PubMed ID: 28717651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic artery embolization with polyethylene glycol microspheres: evaluation in a canine spontaneous benign prostatic hyperplasia model.
    Lucas Cava V; Sánchez Margallo FM; Báez Díaz C; Dávila Gómez L; Lima Rodríguez JR; Sun F
    CVIR Endovasc; 2020 Sep; 3(1):44. PubMed ID: 32886265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A correlation study between prostate necrosis rate calculated by 3D Slicer software and clinical efficacy of prostatic artery embolization, along with an analysis of predictors of clinical success after prostatic artery embolization.
    Wang RL; Lin FF; Ruan DD; Li SJ; Zhou YF; Luo JW; Fang ZT; Tang Y
    Abdom Radiol (NY); 2024 Mar; 49(3):927-938. PubMed ID: 38158423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Clinical Outcome after Prostate Artery Embolization with Spherical and Nonspherical Polyvinyl Alcohol Particles in Patients with Benign Prostatic Hyperplasia.
    Bilhim T; Pisco J; Pereira JA; Costa NV; Fernandes L; Campos Pinheiro L; Duarte M; Oliveira AG
    Radiology; 2016 Oct; 281(1):289-300. PubMed ID: 27223621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.
    Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M
    J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.